Verrica Pharmaceuticals Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 7.10 M | $10.29 M | 0.00% | 15.17% |
VANGUARD GROUP INC | 11/13/2024 | 1.29 M | $1.87 M | 1.35% | 2.75% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.09 M | $1.57 M | 100.00% | 2.32% |
FMR LLC | 11/13/2024 | 634,310 | $919,749 | -42.79% | 1.36% |
STATE STREET CORP | 11/14/2024 | 512,821 | $743,590 | 13.51% | 1.10% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 455,480 | $660,520 | -1.70% | 0.97% |
PROPEL BIO MANAGEMENT, LLC | 11/13/2024 | 344,937 | $500,159 | -18.83% | 0.74% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 322,186 | $467,170 | 100.00% | 0.69% |
XTX TOPCO LTD | 11/14/2024 | 231,148 | $335,165 | 100.00% | 0.49% |
SIMPLIFY ASSET MANAGEMENT INC. | 11/12/2024 | 200,000 | $290,000 | -28.57% | 0.43% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 186,132 | $270,000 | 100.00% | 0.40% |
MORGAN STANLEY | 11/14/2024 | 181,781 | $263,583 | 114.01% | 0.39% |
BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 180,000 | $261,000 | 0.00% | 0.38% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 147,964 | $214,548 | 225.02% | 0.32% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 115,284 | $167,162 | 169.39% | 0.25% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 114,363 | $165,827 | -4.63% | 0.24% |
STEEL PEAK WEALTH MANAGEMENT LLC | 10/25/2024 | 101,998 | $147,898 | -16.96% | 0.22% |
KOVITZ INVESTMENT GROUP PARTNERS, LLC | 11/15/2024 | 101,125 | $146,631 | 1.00% | 0.22% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 95,032 | $137,796 | 0.00% | 0.20% |
MARINER, LLC | 11/13/2024 | 89,940 | $130,413 | 414.35% | 0.19% |
SQUAREPOINT OPS LLC | 11/14/2024 | 86,039 | $124,757 | 100.00% | 0.18% |
MIRACLE MILE ADVISORS, LLC | 10/07/2024 | 84,000 | $121,800 | 0.00% | 0.18% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 80,556 | $116,806 | 100.00% | 0.17% |
BECK MACK & OLIVER LLC | 11/13/2024 | 70,000 | $101,500 | 133.33% | 0.15% |
JANE STREET GROUP, LLC | 11/15/2024 | 69,872 | $101,314 | 106.45% | 0.15% |
VERITION FUND MANAGEMENT LLC | 11/14/2024 | 61,640 | $89,378 | 100.00% | 0.13% |
11/25/2024 | 60,000 | $59,670 | 100.00% | 0.13% | |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 57,200 | $82,940 | -30.41% | 0.12% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 51,290 | $74,371 | 0.00% | 0.11% |
HRT FINANCIAL LP | 11/12/2024 | 48,483 | $70,000 | 100.00% | 0.10% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 43,613 | $63,239 | -25.68% | 0.09% |
TWO SIGMA SECURITIES, LLC | 11/14/2024 | 35,980 | $52,171 | 100.00% | 0.08% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 32,140 | $46,603 | 10.25% | 0.07% |
BARCLAYS PLC | 11/19/2024 | 31,341 | $45,000 | 404.60% | 0.07% |
SPC FINANCIAL, INC. | 10/16/2024 | 30,000 | $43,500 | 0.00% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 28,162 | $40,835 | 41.90% | 0.06% |
ROYAL BANK OF CANADA | 11/14/2024 | 25,785 | $37,000 | 824.19% | 0.06% |
SHERBROOKE PARK ADVISERS LLC | 11/14/2024 | 24,865 | $36,054 | 100.00% | 0.05% |
RHUMBLINE ADVISERS | 11/12/2024 | 24,749 | $35,881 | -6.93% | 0.05% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 20,030 | $29,044 | 100.00% | 0.04% |
CREATIVE PLANNING | 10/11/2024 | 19,018 | $27,576 | -36.43% | 0.04% |
ENGINEERS GATE MANAGER LP | 11/14/2024 | 16,617 | $24,095 | 100.00% | 0.04% |
SG AMERICAS SECURITIES, LLC | 10/03/2024 | 14,372 | $21,000 | 100.00% | 0.03% |
STIFEL FINANCIAL CORP | 11/14/2024 | 13,914 | $20,178 | -19.80% | 0.03% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 12,200 | $17,690 | 0.00% | 0.03% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/28/2024 | 11,500 | $17,000 | 0.00% | 0.02% |
TRUIST FINANCIAL CORP | 11/13/2024 | 10,545 | $15,290 | 0.00% | 0.02% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 10,400 | $15,080 | -8.68% | 0.02% |
COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 10,124 | $14,680 | -0.61% | 0.02% |
FINTRUST CAPITAL ADVISORS, LLC | 10/11/2024 | 10,000 | $14,500 | 100.00% | 0.02% |
Verrica Pharmaceuticals Inc.institutional Ownership - FAQ's
During the previous two years, 93 institutional investors and hedge funds held shares of Verrica Pharmaceuticals Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 7.1 M
VANGUARD GROUP INC: 1.29 M
BlackRock Funding, Inc. /DE: 1.09 M
FMR LLC: 634,310
STATE STREET CORP: 512,821
GEODE CAPITAL MANAGEMENT, LLC: 455,480
31.82% of Verrica Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.84 M shares in the last 24 months. This purchase volume represents approximately $11.09 M in transactions.